With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2K3Kxfc
via IFTTT
Mega diabetes drug to be cheaper soon
With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2K3Kxfc
via IFTTT
0 comments:
Post a Comment